A share price of Jade Biosciences Inc [JBIO] is currently trading at $11.50, down -7.85%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The JBIO shares have gain 17.35% over the last week, with a monthly amount glided 25.29%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Jade Biosciences Inc [NASDAQ: JBIO] stock has seen the most recent analyst activity on May 05, 2025, when Stifel initiated its Buy rating and assigned the stock a price target of $19. Previously, TD Cowen started tracking the stock with Buy rating on May 02, 2025, and set its price target to $10. On June 18, 2024, downgrade downgraded it’s rating to Equal Weight and revised its price target to $2 on the stock. TD Cowen downgraded its rating to a Hold. Evercore ISI downgraded its rating to a In-line and reduced its price target to $2 on June 18, 2024. Wedbush downgraded its rating to Neutral for this stock on June 17, 2024, and downed its price target to $3. In a note dated June 17, 2024, Guggenheim downgraded an Neutral rating on this stock.
Jade Biosciences Inc experienced fluctuations in its stock price throughout the past year between $4.57 and $92.46. Jade Biosciences Inc [NASDAQ: JBIO] shares were valued at $11.50 at the most recent close of the market.
Analyzing the JBIO fundamentals
Gross Profit Margin for this corporation currently stands at None% with Operating Profit Margin at None%, Pretax Profit Margin comes in at None%, and Net Profit Margin reading is None%. To continue investigating profitability, this company’s Return on Assets is posted at None, Equity is None and Total Capital is None. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio ofNone.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.95 points at the first support level, and at 10.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.53, and for the 2nd resistance point, it is at 13.55.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Jade Biosciences Inc [NASDAQ:JBIO] is 32.01. In addition, the Quick Ratio stands at 32.01 and the Cash Ratio stands at None.
Transactions by insiders
Recent insider trading involved RA CAPITAL MANAGEMENT, L.P., Director, that happened on Jun 17 ’24 when 0.93 million shares were purchased., Eldridge George A completed a deal on Jun 14 ’24 to sell 15000.0 shares. Meanwhile, CHIEF TECHNICAL OFFICER Verwijs Marinus sold 10600.0 shares on Jun 14 ’24.
